Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.05% inched 0.57% higher to $164.86 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.37% rising 1.21% to 4,448.98 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.43% rising 1.48% to 34,764.82. Johnson & Johnson closed $15.06 below its 52-week high ($179.92), which the company reached on August 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF -1.68% rose 0.01% to $374.99, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +1.99% rose 1.40% to $73.05, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +1.69% rose 0.55% to $44.19. Trading volume (4.7 M) remained 1.1 million below its 50-day average volume of 5.8 M.